Financhill
Sell
47

COP Quote, Financials, Valuation and Earnings

Last price:
$93.26
Seasonality move :
0.04%
Day range:
$92.29 - $95.08
52-week range:
$79.88 - $122.17
Dividend yield:
3.31%
P/E ratio:
11.97x
P/S ratio:
1.98x
P/B ratio:
1.82x
Volume:
8.3M
Avg. volume:
8.9M
1-year change:
-22.55%
Market cap:
$118.9B
Revenue:
$54.7B
EPS (TTM):
$7.87
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $18.8B $45.8B $78.5B $56.1B $54.7B
Revenue Growth (YoY) -42.32% 143.97% 71.28% -28.48% -2.49%
 
Cost of Revenues $17.9B $31.1B $48.5B $37.9B $38.4B
Gross Profit $841M $14.8B $30B $18.2B $16.4B
Gross Profit Margin 4.48% 32.23% 38.24% 32.42% 29.93%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $430M $719M $623M $705M $1.2B
Other Inc / (Exp) -$382M $1.7B $3.6B $1.9B $1.6B
Operating Expenses $2.6B $2.7B $4.6B $3.2B $3.6B
Operating Income -$1.8B $12.1B $25.5B $15B $12.8B
 
Net Interest Expenses $958M $1.1B $860M $651M $706M
EBT. Incl. Unusual Items -$3.1B $12.7B $28.2B $16.3B $13.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$485M $4.6B $9.5B $5.3B $4.4B
Net Income to Company -$2.7B $8.1B $18.7B $11B $9.2B
 
Minority Interest in Earnings -$46M -- -- -- --
Net Income to Common Excl Extra Items -$2.7B $8.1B $18.7B $11B $9.2B
 
Basic EPS (Cont. Ops) -$2.51 $6.09 $14.62 $9.08 $7.82
Diluted EPS (Cont. Ops) -$2.51 $6.07 $14.57 $9.06 $7.81
Weighted Average Basic Share $1.1B $1.3B $1.3B $1.2B $1.2B
Weighted Average Diluted Share $1.1B $1.3B $1.3B $1.2B $1.2B
 
EBITDA $3.4B $21.1B $37.1B $25.8B $24.4B
EBIT -$2.1B $13.8B $29.3B $17.4B $14.8B
 
Revenue (Reported) $18.8B $45.8B $78.5B $56.1B $54.7B
Operating Income (Reported) -$1.8B $12.1B $25.5B $15B $12.8B
Operating Income (Adjusted) -$2.1B $13.8B $29.3B $17.4B $14.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $9.8B $17.8B $14.8B $13.8B $16.5B
Revenue Growth (YoY) 59.57% 80.77% -16.61% -6.5% 19.27%
 
Cost of Revenues $7.8B $10.2B $9.9B $9.6B $11.4B
Gross Profit $2.1B $7.6B $5B $4.3B $5.1B
Gross Profit Margin 21.11% 42.83% 33.44% 30.97% 30.74%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $311M $187M $159M $178M $191M
Other Inc / (Exp) $693M $1.6B $739M $650M $547M
Operating Expenses $765M $1.1B $873M $845M $859M
Operating Income $1.3B $6.5B $4.1B $3.4B $4.2B
 
Net Interest Expenses $288M $278M $256M $285M $299M
EBT. Incl. Unusual Items $1.7B $7.9B $4.6B $3.8B $4.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $732M $2.1B $1.6B $1.3B $1.6B
Net Income to Company $982M $5.8B $2.9B $2.6B $2.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $982M $5.8B $2.9B $2.6B $2.8B
 
Basic EPS (Cont. Ops) $0.75 $4.41 $2.38 $2.16 $2.23
Diluted EPS (Cont. Ops) $0.75 $4.39 $2.38 $2.15 $2.23
Weighted Average Basic Share $1.3B $1.3B $1.2B $1.2B $1.3B
Weighted Average Diluted Share $1.3B $1.3B $1.2B $1.2B $1.3B
 
EBITDA $3.9B $10B $6.8B $6.3B $7.6B
EBIT $2B $8.2B $4.8B $4.1B $4.8B
 
Revenue (Reported) $9.8B $17.8B $14.8B $13.8B $16.5B
Operating Income (Reported) $1.3B $6.5B $4.1B $3.4B $4.2B
Operating Income (Adjusted) $2B $8.2B $4.8B $4.1B $4.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $22.5B $53.8B $75.5B $55.2B $57.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $20.5B $33.5B $48.2B $37.6B $40.2B
Gross Profit $2B $20.3B $27.4B $17.5B $17.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $744M $595M $595M $724M $1.2B
Other Inc / (Exp) $2.1B $2.7B $2.7B $1.8B $1.5B
Operating Expenses $3B $3B $4.4B $3.1B $3.6B
Operating Income -$969M $17.3B $23B $14.4B $13.6B
 
Net Interest Expenses $977M $1.1B $838M $680M $720M
EBT. Incl. Unusual Items $137M $18.9B $24.9B $15.5B $14.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $99M $6B $9.1B $4.9B $4.8B
Net Income to Company $38M $12.9B $15.8B $10.6B $9.5B
 
Minority Interest in Earnings -$18M -- -- -- --
Net Income to Common Excl Extra Items $20M $12.9B $15.8B $10.6B $9.5B
 
Basic EPS (Cont. Ops) -$0.15 $9.73 $12.53 $8.86 $7.89
Diluted EPS (Cont. Ops) -$0.15 $9.70 $12.50 $8.83 $7.87
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $7.2B $27.2B $34B $25.3B $25.7B
EBIT $1.2B $20B $25.9B $16.6B $15.5B
 
Revenue (Reported) $22.5B $53.8B $75.5B $55.2B $57.4B
Operating Income (Reported) -$969M $17.3B $23B $14.4B $13.6B
Operating Income (Adjusted) $1.2B $20B $25.9B $16.6B $15.5B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $9.8B $17.8B $14.8B $13.8B $16.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7.8B $10.2B $9.9B $9.6B $11.4B
Gross Profit $2.1B $7.6B $5B $4.3B $5.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $311M $187M $159M $178M $191M
Other Inc / (Exp) $693M $1.6B $739M $650M $547M
Operating Expenses $765M $1.1B $873M $845M $859M
Operating Income $1.3B $6.5B $4.1B $3.4B $4.2B
 
Net Interest Expenses $288M $278M $256M $285M $299M
EBT. Incl. Unusual Items $1.7B $7.9B $4.6B $3.8B $4.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $732M $2.1B $1.6B $1.3B $1.6B
Net Income to Company $982M $5.8B $2.9B $2.6B $2.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $982M $5.8B $2.9B $2.6B $2.8B
 
Basic EPS (Cont. Ops) $0.75 $4.41 $2.38 $2.16 $2.23
Diluted EPS (Cont. Ops) $0.75 $4.39 $2.38 $2.15 $2.23
Weighted Average Basic Share $1.3B $1.3B $1.2B $1.2B $1.3B
Weighted Average Diluted Share $1.3B $1.3B $1.2B $1.2B $1.3B
 
EBITDA $3.9B $10B $6.8B $6.3B $7.6B
EBIT $2B $8.2B $4.8B $4.1B $4.8B
 
Revenue (Reported) $9.8B $17.8B $14.8B $13.8B $16.5B
Operating Income (Reported) $1.3B $6.5B $4.1B $3.4B $4.2B
Operating Income (Adjusted) $2B $8.2B $4.8B $4.1B $4.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $3B $5B $6.5B $5.6B $5.6B
Short Term Investments $4.9B $1.6B $2.8B $971M $507M
Accounts Receivable, Net $2.8B $6.7B $7.1B $5.5B $6.7B
Inventory $1B $1.2B $1.2B $1.4B $1.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $454M $1.6B $1.2B $852M $1B
Total Current Assets $12.1B $16.1B $18.7B $14.3B $15.6B
 
Property Plant And Equipment $39.9B $64.9B $64.9B $70B $94.4B
Long-Term Investments $7.9B $7B $8.1B $9B $9.8B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.5B $2.6B $2B $2.4B $2.9B
Total Assets $62.6B $90.7B $93.8B $95.9B $122.8B
 
Accounts Payable $2.7B $5B $6.2B $5.1B $6B
Accrued Expenses $1.1B $2.2B $2.3B $1.2B $1.5B
Current Portion Of Long-Term Debt $451M $920M $133M $783M $743M
Current Portion Of Capital Lease Obligations $168M $280M $284M $291M $292M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $5.4B $12B $12.8B $10B $12.1B
 
Long-Term Debt $14B $17.8B $15.2B $17B $22.6B
Capital Leases -- -- -- -- --
Total Liabilities $32.8B $45.3B $45.8B $46.6B $58B
 
Common Stock $18M $21M $21M $21M $23M
Other Common Equity Adj -$5.2B -$5B -$6B -$5.7B -$6.5B
Common Equity $29.8B $45.4B $48B $49.3B $64.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $29.8B $45.4B $48B $49.3B $64.8B
 
Total Liabilities and Equity $62.6B $90.7B $93.8B $95.9B $122.8B
Cash and Short Terms $7.9B $6.6B $9.2B $6.6B $6.1B
Total Debt $14.5B $18.7B $15.3B $17.8B $23.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $2.8B $6.4B $7B $5.6B $6.3B
Short Term Investments $5.7B $730M $1.6B $487M $926M
Accounts Receivable, Net $4.5B $7.9B $5.3B $5.5B $6.4B
Inventory $1.1B $1.2B $1.3B $1.4B $1.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $536M $1.4B $953M $759M $1.4B
Total Current Assets $14.6B $17.6B $16.1B $13.7B $16.9B
 
Property Plant And Equipment $58.3B $64.6B $65.1B $69.9B $94.3B
Long-Term Investments $8.3B $8.3B $8.2B $9.1B $10B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.5B $2.8B $2B $2.6B $3B
Total Assets $83.7B $93.3B $91.4B $95.3B $124.3B
 
Accounts Payable $3.8B $4.9B $5.1B $5.1B $7.3B
Accrued Expenses $1.2B $2B $1.9B $1.4B $1.8B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $7.2B $11.6B $11.6B $10.2B $13.3B
 
Long-Term Debt $19.3B $17.6B $15.3B $17.3B $23.2B
Capital Leases -- -- -- -- --
Total Liabilities $40.5B $44.1B $43.7B $46B $59B
 
Common Stock $21M $21M $21M $21M $23M
Other Common Equity Adj -$5.1B -$4.8B -$6B -$5.9B -$6.4B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $43.2B $49.2B $47.8B $49.3B $65.2B
 
Total Liabilities and Equity $83.7B $93.3B $91.4B $95.3B $124.3B
Cash and Short Terms $8.5B $7.1B $8.6B $6.1B $7.2B
Total Debt $20B $18.7B $16.6B $18.4B $23.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$2.7B $8.1B $18.7B $11B $9.2B
Depreciation & Amoritzation -- $7.2B $7.5B $8.3B $9.6B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $521M -$2.5B -$963M $1.3B -$262M
Change in Inventories -$25M -$160M -$38M -$103M -$68M
Cash From Operations $4.8B $17B $28.3B $20B $20.1B
 
Capital Expenditures $4.7B $5.3B $10.2B $11.2B $12.1B
Cash Acquisitions -- -$8.3B -$60M -$2.7B -$24M
Cash From Investing -$4.1B -$8.5B -$8.7B -$12B -$11.2B
 
Dividends Paid (Ex Special Dividend) -$1.8B -$2.4B -$5.7B -$5.6B -$3.6B
Special Dividend Paid
Long-Term Debt Issued $300M -- $2.9B $3.8B $5.6B
Long-Term Debt Repaid -$254M -$505M -$6.3B -$1.4B -$5B
Repurchase of Common Stock -$897M -$3.6B -$9.3B -$5.5B -$5.5B
Other Financing Activities -$26M $7M -$49M -$34M -$258M
Cash From Financing -$2.7B -$6.3B -$18.1B -$8.7B -$8.8B
 
Beginning Cash (CF) $5.4B $3.3B $5.4B $6.7B $5.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2B $2.1B $1.5B -$696M $139M
Ending Cash (CF) $3.3B $5.4B $6.7B $5.9B $5.9B
 
Levered Free Cash Flow $87M $11.7B $18.2B $8.7B $8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $982M $5.8B $2.9B $2.6B $2.8B
Depreciation & Amoritzation -- -- $1.9B $2.2B $2.7B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$785M -$1.5B $1.7B -$76M $280M
Change in Inventories -$51M $27M -$45M -$55M -$26M
Cash From Operations $2.1B $5.1B $5.4B $5B $6.1B
 
Capital Expenditures $1.2B $3.2B $2.9B $2.9B $3.4B
Cash Acquisitions $382M $37M -- $49M --
Cash From Investing -$1.2B -$611M -$1.4B -$2.1B -$2.3B
 
Dividends Paid (Ex Special Dividend) -$588M -$864M -$1.5B -$924M -$998M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $2.9B -- -- --
Long-Term Debt Repaid -$26M -$4B -$43M -$505M -$547M
Repurchase of Common Stock -$403M -$1.4B -$1.8B -$1.4B -$1.6B
Other Financing Activities $2M -$52M $2M -$10M -$40M
Cash From Financing -$1B -$3.1B -$3.3B -$2.8B -$3.1B
 
Beginning Cash (CF) $3.3B $5.4B $6.7B $5.9B $5.9B
Foreign Exchange Rate Adjustment -$2M $21M -$104M -$73M $83M
Additions / Reductions -$150M $1.3B $629M $19M $632M
Ending Cash (CF) $3.2B $6.7B $7.2B $5.8B $6.6B
 
Levered Free Cash Flow $880M $1.9B $2.5B $2.1B $2.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $38M $12.9B $15.8B $10.6B $9.5B
Depreciation & Amoritzation -- -- -- $8.5B $10.1B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.3B -$3.3B $2.3B -$444M $94M
Change in Inventories -$353M -$82M -$110M -$113M -$39M
Cash From Operations $4.8B $20B $28.6B $19.5B $21.3B
 
Capital Expenditures $4.3B $7.3B $9.9B $11.3B $12.6B
Cash Acquisitions $382M -$8.6B -$97M -$2.7B -$73M
Cash From Investing -$3.4B -$7.9B -$9.6B -$12.7B -$11.4B
 
Dividends Paid (Ex Special Dividend) -$2B -$2.6B -$6.4B -$5B -$3.7B
Special Dividend Paid
Long-Term Debt Issued -- $2.9B -- -- --
Long-Term Debt Repaid -$256M -$4.4B -$2.3B -$1.8B -$5B
Repurchase of Common Stock -$574M -$4.6B -$9.6B -$5B -$5.7B
Other Financing Activities -- -$47M $5M -$46M -$288M
Cash From Financing -$2.5B -$8.5B -$18.2B -$8.2B -$9.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.1B $3.6B $829M -$1.3B $752M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $511M $12.7B $18.8B $8.3B $8.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $982M $5.8B $2.9B $2.6B $2.8B
Depreciation & Amoritzation -- -- $1.9B $2.2B $2.7B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$785M -$1.5B $1.7B -$76M $280M
Change in Inventories -$51M $27M -$45M -$55M -$26M
Cash From Operations $2.1B $5.1B $5.4B $5B $6.1B
 
Capital Expenditures $1.2B $3.2B $2.9B $2.9B $3.4B
Cash Acquisitions $382M $37M -- $49M --
Cash From Investing -$1.2B -$611M -$1.4B -$2.1B -$2.3B
 
Dividends Paid (Ex Special Dividend) -$588M -$864M -$1.5B -$924M -$998M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $2.9B -- -- --
Long-Term Debt Repaid -$26M -$4B -$43M -$505M -$547M
Repurchase of Common Stock -$403M -$1.4B -$1.8B -$1.4B -$1.6B
Other Financing Activities $2M -$52M $2M -$10M -$40M
Cash From Financing -$1B -$3.1B -$3.3B -$2.8B -$3.1B
 
Beginning Cash (CF) $3.3B $5.4B $6.7B $5.9B $5.9B
Foreign Exchange Rate Adjustment -$2M $21M -$104M -$73M $83M
Additions / Reductions -$150M $1.3B $629M $19M $632M
Ending Cash (CF) $3.2B $6.7B $7.2B $5.8B $6.6B
 
Levered Free Cash Flow $880M $1.9B $2.5B $2.1B $2.7B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 14.04% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.44% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 1.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock